This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Valo Health, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christophe Benelli: Inventor of a Rho-Kinase Inhibitor Intermediate
Introduction
Christophe Benelli is an inventor associated with Boston, Massachusetts, and Valo Health, Inc. His patent work concerns chemical processes and compounds relevant to the preparation of Rho-kinase inhibitors.
Latest Patents
Benelli is named on 1 patent: “Process for Preparing 6-Substituted-1-(2H)-Isoquinolinones and Intermediate Compound.” The invention describes substituted isoquinoline oxide compounds and a process for preparing them. These compounds can serve as intermediates for making 6-substituted-1-(2H)-isoquinolinones, which inhibit the enzyme Rho-kinase or can be used to prepare further Rho-kinase inhibitors.
Career Highlights
The patent reflects Benelli’s contribution to medicinal chemistry and the development of synthetic routes for compounds with potential use in enzyme inhibition. His listed company affiliation is Valo Health, Inc.
Collaborations
Benelli’s named coworkers include Par Holmberg and Matthew James Wathier.
Conclusion
Christophe Benelli’s documented invention focuses on chemical intermediates and a preparation process connected to Rho-kinase inhibitors, highlighting his contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
